226 related articles for article (PubMed ID: 1084880)
1. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
Treves AJ; Cohen IR; Feldman M
Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro.
Treves AJ; Cohen IR; Feldman M
J Natl Cancer Inst; 1975 Mar; 54(3):777-80. PubMed ID: 1123855
[TBL] [Abstract][Full Text] [Related]
3. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
4. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
[TBL] [Abstract][Full Text] [Related]
5. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
Nagarkatti M; Toney DM; Nagarkatti PS
Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
[TBL] [Abstract][Full Text] [Related]
7. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
8. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
Spasokukotskiĭ AL
Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik M; Dougherty GJ
Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
[TBL] [Abstract][Full Text] [Related]
11. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
Gorelik E; Fogel M; Segal S; Feldman M
J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
Olsson L; Kiger N; Kronstrom H
Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
[TBL] [Abstract][Full Text] [Related]
14. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
Treves AJ; Carnaud C; Trainin N; Feldman M; Cohen IR
Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
[No Abstract] [Full Text] [Related]
15. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
Arkhipov SA; Iunker VM; Gruntenko EV
Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
[TBL] [Abstract][Full Text] [Related]
16. Activation of suppressor cells by syngeneic tumor transplants in mice.
Argyris BF
Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
[TBL] [Abstract][Full Text] [Related]
17. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
18. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
[TBL] [Abstract][Full Text] [Related]
19. Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice.
Malavé I; Blanca I; Fuji H
J Natl Cancer Inst; 1979 Jan; 62(1):83-8. PubMed ID: 281579
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the immature cells involved in T cell-mediated enhancement of syngeneic tumor growth.
Small M
J Immunol; 1977 May; 118(5):1517-23. PubMed ID: 300747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
